Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
BB Biotech AG

BB Biotech AG (BION.SW) Stock Overview

Explore BB Biotech AG’s financial performance, market position, analyst ratings, and future outlook.

BION.SW●SIX
Financial ServicesAsset Management
CHF54.50
CHF1.40(2.64%)
Swiss Market opens in 10h 13m

BB Biotech AG (BION.SW)

Meyka AI Score

Z

Key Financials

Market Cap3B
P/E Ratio2.17
EPS (TTM)$-5.53
ROE0.50%
Fundamental Analysis

AI Price Forecasts

1 Month$53.48
3 Months$58.56
1 Year Target$58.36

BION.SW Stock Analysis & Investment Overview (SIX)

Our AI-powered analysis of BB Biotech AG (SIX: BION.SW) gives investors deep insight into how the stock performs on the SIX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, BB Biotech AG's SIX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BION.SW on the SIX shows an RSI of 63.48, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $58.36 for the SIX listing.

Key metrics behind BB Biotech AG's SIX-traded stock include a P/E ratio of 2.17 and a market capitalization of 3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BION.SW on the SIX.

Price Performance (SIX: BION.SW)

1-Day Change
2.64%
5-Day Change
2.06%
1-Month Change
9.99%
3-Month Change
21.92%
6-Month Change
17.84%
Year-to-Date (YTD) Change
25.72%
1-Year Change
65.15%
3-Year Change
32.44%
5-Year Change
-38.21%
All-Time (Max) Change
157.56%

Contact Information

https://www.bbbiotech.ch/ch-en/private
41 44 267 67 00
Seestrasse 16, Kusnacht, NaN, CH-8700

Company Facts

100 Employees
IPO DateDec 27, 1993
CountryCH
Actively Trading

Frequently Asked Questions